PUBLISHER: The Business Research Company | PRODUCT CODE: 1942639
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942639
Cryopreservation equipment encompasses specialized devices used to store biological specimens-such as cells, tissues, and organs-at extremely low temperatures, typically below -150°C. These instruments include cryogenic storage tanks, freezers, and other associated accessories that employ either liquid nitrogen or mechanical refrigeration systems to suspend biological activity. This preservation method ensures the long-term viability and function of samples, making them suitable for use in biobanking, regenerative medicine, and various research applications.
The primary categories of cryopreservation equipment consist of freezers, incubators, sample preparation systems, and complementary accessories. Freezers are designed to maintain ultra-low temperatures and include types such as ultra-low temperature (ULT) freezers, mechanical freezers, cryogenic freezers, liquid nitrogen freezers, and portable models. These tools are applied in preserving a variety of biological materials including cord blood stem cells, sperm, semen, testicular tissues, embryos, and oocytes. They are utilized by a range of end users, including stem cell banks, contract research organizations, pharmaceutical and biotechnology companies, academic and research institutions, and stem cell research laboratories.
Tariffs are impacting the cryopreservation equipment market by increasing the cost of imported freezers, incubators, and cryogenic accessories. Segments such as ultra-low temperature freezers, liquid nitrogen storage tanks, and automated sample preparation systems are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to elevated production costs and supply chain adjustments. Positively, tariffs are encouraging local manufacturing, innovation in cost-efficient cryogenic solutions, and increased investment in domestic production capacities.
The cryopreservation equipment market research report is one of a series of new reports from The Business Research Company that provides cryopreservation equipment market statistics, including cryopreservation equipment industry global market size, regional shares, competitors with a cryopreservation equipment market share, detailed cryopreservation equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cryopreservation equipment industry. This cryopreservation equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryopreservation equipment market size has grown rapidly in recent years. It will grow from $11.01 billion in 2025 to $12.74 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to limited availability of ultra-low temperature freezers, reliance on manual sample preparation methods, growing stem cell banking activities, increasing research in regenerative medicine, adoption of standard cryogenic safety protocols.
The cryopreservation equipment market size is expected to see rapid growth in the next few years. It will grow to $22.53 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to technological advancements in automated freezing and thawing systems, rising investment in biobanking and stem cell research, growing demand for embryo and oocyte preservation, increased regulatory compliance and quality certifications, integration of smart monitoring and IoT-enabled cryogenic devices. Major trends in the forecast period include rising demand for ultra-low temperature freezers and cryogenic equipment, increased adoption of automated sample preparation systems, expansion of stem cell and embryo preservation applications, growth in temperature monitoring and safety compliance solutions, enhanced focus on portable and modular cryopreservation equipment.
The increasing demand for regenerative medicines is expected to propel the growth of the cryopreservation equipment market going forward. Regenerative medicines refer to therapies that repair, replace, or regenerate damaged tissues or organs to restore normal function. The rise in demand for regenerative medicines is driven by their potential to restore damaged tissues, offering long-term solutions and reducing the need for repeated treatments. Cryopreservation equipment supports regenerative medicines by enabling the long-term storage of cells, tissues, and other biological materials without compromising their viability or therapeutic potential. For instance, in January 2025, according to the catapult, a UK-based biotechnology company, clinical trials, including gene therapies, cell therapies, and tissue-engineered products, in 2024 accounted for 9.5% of global trials and nearly 50% of all European trials. These clinical trials support the expansion of regenerative medicine. Therefore, the increasing demand for regenerative medicines is driving the cryopreservation equipment market.
Major companies operating in the cryopreservation equipment market are focusing on developing innovative solutions, such as one-stop hubs for cell and gene therapy, to streamline the preservation, storage, and transport of biological materials, enhance process efficiency, and support the rapid commercialization of advanced therapies. One-stop hubs for cell and gene therapy refer to integrated facilities that provide comprehensive services from processing and cryopreservation to storage and distribution within a single location. For instance, in October 2024, Cryoport Inc., a US-based temperature-controlled supply chain solutions provider for life sciences, launched its IntegriCell cryopreservation services. The service is offered through Cryoport Systems at a newly opened, advanced facility on its Houston supply chain campus. This facility focuses on standardized cryopreservation of leukapheresis material. It integrates seamlessly with Cryoport's global logistics platform to support cell therapy development and commercialization. The move strengthens Cryoport's capabilities in biostorage and cell therapy logistics.
In April 2025, BioLife Solutions, a US-based biotechnology company, acquired PanTHERA CryoSolutions for an undisclosed amount. This acquisition strengthens BioLife's position in the bio preservation sector by broadening its range of consumables and adding scientific depth to its leadership team. PanTHERA CryoSolutions Inc. is a Canada-based firm focused on producing cryopreservation products.
Major companies operating in the cryopreservation equipment market are Thermo Fisher Scientific Inc, Linde LLC, Danaher Corporation, Merck KGaA, Avantor Inc, Beckman Coulter Inc, PHC Corporation, Chart Biomedical Co Ltd, Hamilton Company, Azenta Life Sciences, Cryoport Systems Inc, Chemglass Life Sciences Inc, BioLife Solutions Inc, Charter Medicals, Planer PLC, CellBios Healthcare And Lifesciences Pvt Ltd, Cryologic Pty Ltd, Bluechiip Ltd, Haimen United Laboratory Equipment Development Co Ltd, Taylor Wharton Cryogenics, Panasonic Healthcare Holdings, CBS Scientific Company
North America was the largest region in the cryopreservation equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryopreservation equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cryopreservation equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cryopreservation equipment market consists of sales of freezers, incubators, cryogenic storage tanks, sample preparation systems, and accessories used for freezing and storing biological materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cryopreservation Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cryopreservation equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cryopreservation equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryopreservation equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.